Emergent BioSolutions Inc/ US29089Q1058 /
4/21/2021 9:59:55 PM | Chg. +0.50 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
65.97USD | +0.76% | 54,893 Turnover: 3.61 mill. |
-Bid Size: - | -Ask Size: - | 3.52 bill.USD | 0.00% | 62.26 |
Assets
|
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 331.9000 | 376.4000 | 407.2000 | 510.2000 | 542.3000 | ||||||
Intangible Assets | 57.4000 | 33.9000 | 119.6000 | 761.6000 | 712.9000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 76.9000 | 74 | 142.8000 | 205.8000 | 222.5000 | ||||||
Accounts Receivable | 120.8000 | 138.5000 | 143.7000 | 262.5000 | 270.7000 | ||||||
Cash and Cash Equivalents | 312.8000 | 271.5000 | 178.3000 | 112.2000 | 167.8000 | ||||||
Current Assets | 538.6000 | 510.2000 | 485.4000 | 620.8000 | 686.2000 | ||||||
Total Assets | 1,043.6000 | 970.1000 | 1,070.2000 | 2,229.4000 | 2,327.3000 |
Liabilities
|
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 46 | 34.6000 | 41.8000 | 80.7000 | 94.8000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | 72 | 63.9000 | ||||||
Liabilities | 383.6000 | 373.9000 | 157.9000 | 1,218.5000 | 1,238.8000 | ||||||
Share Capital | .0400 | .0410 | .0500 | .1000 | .1000 | ||||||
Total Equity | 660 | 596.2000 | 912.3000 | 1,010.9000 | 1,088.5000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 1,043.6000 | 970.1000 | 1,070.2000 | 2,229.4000 | 2,327.3000 |
Income Statement
|
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 522.8000 | 488.8000 | 560.9000 | 782.4000 | 1,106 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 96 | 105.5000 | 124.3000 | 89.8000 | 114.1000 | ||||||
Interest Income | -5.9000 | -6.5000 | -4.8000 | -9.9000 | -38.4000 | ||||||
Income Before Taxes | 89.8000 | 99.2000 | 118.6000 | 81.5000 | 77.4000 | ||||||
Income Taxes | 26.9000 | 36.7000 | 36 | 18.8000 | 22.9000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | 62.9000 | 51.8000 | 82.6000 | 62.7000 | 54.5000 |
Per Share
Cash Flow
|
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 44.5000 | 53.5000 | 208.1000 | 41.8000 | 188 | ||||||
Cash Flow from Investing Activities | -45.5000 | -76.3000 | -249.9000 | -897.2000 | -96.9000 | ||||||
Cash Flow from Financing | 33.4000 | -18.6000 | -51.4000 | 788.7000 | -35.9000 | ||||||
Decrease / Increase in Cash | 32.3000 | -41.3000 | -93.2000 | -66.9000 | 55.6000 | ||||||
Employees | 1,292 | 1,098 | 1,256 | 1,705 | 1,834 |